Saturday, November 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 23, 2026

Is It Too Late To Consider Ford (F) After Its 51% One Year Surge?

View original at finance.yahoo.com
Is It Too Late To Consider Ford (F) After Its 51% One Year Surge? Never miss an important update on your stock portfolio and cut through the noise…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Ford Motor's 3-year return is 49.1% and 5-year return is 38.6%

    60% confidence
  • Ford Motor is undervalued by 13.8% based on DCF analysis, with an estimated intrinsic value of $17.33 per share versus a market price of approximately $14.93

    60% confidence
  • There are 49 additional high quality undervalued stocks identified beyond Ford Motor

    60% confidence
  • The P/S ratio is a useful valuation metric for companies generating meaningful revenue, especially when earnings are volatile or distorted by one-off items

    60% confidence
  • Ford Motor currently scores 4 out of 6 on Simply Wall St's valuation checks

    60% confidence
  • Over 7 million investors trust Simply Wall St to stay informed about their stock portfolios

    60% confidence
  • Ford Motor is currently generating trailing twelve month free cash flow of approximately $9.83 billion

    60% confidence
  • Projected free cash flow for Ford Motor in 2028 is $7.74 billion, with additional estimates extending through 2035

    60% confidence
  • Ford Motor stock returned 11.4% over the past week, 18.2% over the past month, 11.9% year-to-date, and 51.2% over the past year

    60% confidence

Data points we hold from this source

Ford Motor Company · cash7.74 USD
Ford Motor Company · stock price14.93 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,580 source documents archived
Query this data → isubstrate.com
Is It Too Late To Consider Ford (F) After Its 51% One Year Surge? — Source | Via News | finance.via.news